TABLE 2.
Metabolites | Retention time (min) | Mass-to-charge ratio | VIP value | Fold change | P-value |
Between the AIS and HCs groups | |||||
Oleic acid | 5.116 | 281.249 | 2.107 | 2.216 | <0.00001 |
Linoleic acid | 4.465 | 279.233 | 1.844 | 1.970 | 0.00001 |
Cer (d18:0/14:0) | 8.993 | 512.503 | 1.735 | 0.212 | <0.00001 |
Cer (d18:0/16:0) | 9.546 | 540.534 | 1.732 | 0.213 | <0.00001 |
Arachidonic acid | 4.421 | 303.233 | 1.556 | 1.564 | 0.00030 |
Non-adecanoic acid | 6.306 | 297.280 | 1.371 | 0.652 | <0.00001 |
Docosahexaenoic acid | 4.207 | 327.233 | 1.306 | 1.342 | 0.00964 |
4-Hydroxyproline | 5.939 | 132.066 | 1.270 | 0.520 | <0.00001 |
PE[18:2(9Z,12Z)/18:1(9Z)] | 8.534 | 742.538 | 1.099 | 0.492 | <0.00001 |
PE[18:2(9Z,12Z)/18:0] | 8.989 | 744.553 | 1.099 | 0.514 | <0.00001 |
L-Palmitoylcarnitine | 1.433 | 400.342 | 1.098 | 1.338 | <0.00001 |
Propionylcarnitine | 2.604 | 218.139 | 1.097 | 0.716 | <0.00001 |
Tetradecanoylcarnitine | 1.473 | 372.311 | 1.095 | 1.382 | 0.00015 |
L-Glutamine | 6.353 | 147.077 | 1.094 | 0.810 | <0.00001 |
L-Arginine | 7.316 | 175.119 | 1.093 | 0.742 | <0.00001 |
Dodecanoylcarnitine | 1.522 | 344.280 | 1.094 | 1.349 | 0.00695 |
L-Proline | 5.346 | 116.071 | 1.092 | 0.758 | <0.00001 |
Decanoylcarnitine | 1.593 | 316.248 | 1.090 | 1.330 | 0.02110 |
Between the LAA and SAO group | |||||
L-Pipecolic acid | 4.735 | 130.087 | 1.578 | 1.790 | 0.00065 |
1-Methylhistidine | 7.267 | 170.093 | 1.317 | 1.625 | 0.04886 |
PE [22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0] | 8.209 | 764.521 | 1.270 | 0.780 | 0.02704 |
PE [P-18:0/18:2(9Z,12Z)] | 9.314 | 728.557 | 1.192 | 1.276 | 0.01645 |
LysoPE [18:2(9Z,12Z)/0:0] | 2.428 | 478.292 | 1.113 | 1.446 | 0.00011 |
LysoPC [18:3(9Z,12Z,15Z)] | 1.991 | 518.323 | 1.045 | 1.387 | 0.00144 |
LysoPC (20:0) | 5.009 | 552.402 | 1.033 | 1.254 | 0.00669 |
LysoPC [18:2(9Z,12Z)] | 2.455 | 520.339 | 1.000 | 1.336 | 0.00013 |
LAA, large artery atherosclerosis; SAO, small artery occlusion; AIC, acute ischemic stroke; HC, healthy control; PE, phosphatidylethanolamine.